Biotech Week Boston Celebrates 10-Year Anniversary with Record Expansion: 5,000+ Global Leaders to Convene
BOSTON, MA, UNITED STATES, September 18, 2026 /EINPresswire.com/ -- Biotech Week Boston (BWB) 2026 will mark its 10-year anniversary with its most ambitious programme to date, bringing together more than 5,000 global attendees from 48 countries at the Hynes Convention Center from September 22–25 for one of the life sciences industry's most significant weeks of the year.
To celebrate this milestone, BWB 2026 introduces Obesity Science & Innovation, a brand-new conference featuring 150+ experts addressing the rapidly expanding obesity therapeutics market, alongside expanded programming across biopharmaceutical manufacturing, cell and gene therapy, RNA therapeutics, investment and partnering.
Spanning the full drug development value chain, Biotech Week Boston uniquely co-locates nine leading events, creating an unparalleled concentration of scientific minds, C-suite executives, investors, academics and service providers under one roof in the heart of one of the world's premier biotech hubs.
What's New for the 10-Year Anniversary
New Event: Obesity Science & Innovation (September 23–24)
Making its debut at BWB 2026, this premier conference brings together thought leaders from Zealand Pharma, Antag Therapeutics, Aphaia Pharma, Eli Lilly, AstraZeneca and University College London to shape the future of obesity and metabolic health therapeutics—one of the fastest-growing segments in biopharma.
Expanded BioProcess International Programming
A new track, CMC Strategy and Manufacturing Performance, empowers leaders to transform their CMC processes through data-driven tools and innovative manufacturing approaches. Featured speakers include Elisabeth Krug, Executive Director at Eli Lilly & Company; Jian Ren, PhD, Principal Scientist at AbbVie; and Tom Gervais, Vice President of Manufacturing at Macrogenics.
Enhanced Investment and Partnering
BioPharm America has merged into LSX Congress USA, combining North America's leading biotech CEO partnering event with Europe's top investment forum into one powerhouse conference for high-value dealmaking and strategic growth conversations.
Biotech Week Boston Campus
A dynamic new feature designed exclusively for early-career scientists and PhD students, offering practical career advice, skill-building opportunities and networking connections tailored to the next generation of biopharma pioneers.
Complete Event Line-Up
Biotech Week Boston Campus (September 23–25) — NEW FOR 2026 — Dedicated programming for early-career scientists and PhD students
Obesity Science & Innovation (September 23–24) — NEW FOR 2026 — Scientific, clinical and commercial advances in obesity research and treatment
BioProcess International (September 22–25) — The leading event for biopharmaceutical process development and manufacturing, featuring five expanded content tracks
Life Sciences Product Launch Summit (September 22) — Commercial strategies for successful therapeutic launches
Cell & Gene Therapy International (September 22–25) — Advancing the next generation of regenerative medicines
LSX Congress USA (September 22–24) — High-value investment, partnering and strategic growth conversations
RNA Leaders USA (September 23–25) — Breakthroughs in mRNA, RNAi, oligonucleotides and delivery technologies
Bioinnovation Group Summit (September 24) — Practical strategies and partnerships to address the barriers limiting innovation adoption
Finance & Accounting for Bioscience (September 24–25) — Financial strategy and capital efficiency for biotech leaders
Industry Leaders and Breakthrough Science
Attendees will gain access to cutting-edge science, practical manufacturing insights, investment opportunities and cross-sector networking that accelerates ideas into partnerships and commercial progress. Highlights include plenary keynotes from industry leaders plus an extensive exhibition showcasing the latest technologies and solutions from more than 250 exhibitors.
"As we celebrate ten years of Biotech Week Boston, we're proud to have created the industry's most comprehensive gathering—where C-suite strategy meets scientific innovation," said Anna Chrisman, President, Pharma and Life Sciences at Informa Connect. "This anniversary edition reflects our industry's evolution. From adding Obesity Science & Innovation to address one of today's most dynamic therapeutic areas, to expanding our manufacturing and investment programming, attendees can move seamlessly from discovery to scale-up, investment and commercialisation—all while connecting with peers shaping the future of medicine."
Media are invited to attend with complimentary press credentials to cover the week's keynotes, panel discussions, exhibition floor and networking events, including the 10th anniversary celebration.
For more information, registration details or media accreditation, please visit: https://informaconnect.com/biotech-week-boston/
About Biotech Week Boston
Biotech Week Boston is an annual series of leading life sciences events taking place across one week in Boston. Now in its 10th year, BWB brings together experts, investors and academics in biologics, bioprocessing, cell and gene therapy, RNA therapeutics, obesity science, AI, data science, and biotechnology—creating a unique opportunity to learn, network, and connect with the wider biotech community.
About Informa Connect Life Sciences
Informa Connect's Life Science Partnering, Investment & Strategy teams' mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference portfolio in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings.
-Ends-
To celebrate this milestone, BWB 2026 introduces Obesity Science & Innovation, a brand-new conference featuring 150+ experts addressing the rapidly expanding obesity therapeutics market, alongside expanded programming across biopharmaceutical manufacturing, cell and gene therapy, RNA therapeutics, investment and partnering.
Spanning the full drug development value chain, Biotech Week Boston uniquely co-locates nine leading events, creating an unparalleled concentration of scientific minds, C-suite executives, investors, academics and service providers under one roof in the heart of one of the world's premier biotech hubs.
What's New for the 10-Year Anniversary
New Event: Obesity Science & Innovation (September 23–24)
Making its debut at BWB 2026, this premier conference brings together thought leaders from Zealand Pharma, Antag Therapeutics, Aphaia Pharma, Eli Lilly, AstraZeneca and University College London to shape the future of obesity and metabolic health therapeutics—one of the fastest-growing segments in biopharma.
Expanded BioProcess International Programming
A new track, CMC Strategy and Manufacturing Performance, empowers leaders to transform their CMC processes through data-driven tools and innovative manufacturing approaches. Featured speakers include Elisabeth Krug, Executive Director at Eli Lilly & Company; Jian Ren, PhD, Principal Scientist at AbbVie; and Tom Gervais, Vice President of Manufacturing at Macrogenics.
Enhanced Investment and Partnering
BioPharm America has merged into LSX Congress USA, combining North America's leading biotech CEO partnering event with Europe's top investment forum into one powerhouse conference for high-value dealmaking and strategic growth conversations.
Biotech Week Boston Campus
A dynamic new feature designed exclusively for early-career scientists and PhD students, offering practical career advice, skill-building opportunities and networking connections tailored to the next generation of biopharma pioneers.
Complete Event Line-Up
Biotech Week Boston Campus (September 23–25) — NEW FOR 2026 — Dedicated programming for early-career scientists and PhD students
Obesity Science & Innovation (September 23–24) — NEW FOR 2026 — Scientific, clinical and commercial advances in obesity research and treatment
BioProcess International (September 22–25) — The leading event for biopharmaceutical process development and manufacturing, featuring five expanded content tracks
Life Sciences Product Launch Summit (September 22) — Commercial strategies for successful therapeutic launches
Cell & Gene Therapy International (September 22–25) — Advancing the next generation of regenerative medicines
LSX Congress USA (September 22–24) — High-value investment, partnering and strategic growth conversations
RNA Leaders USA (September 23–25) — Breakthroughs in mRNA, RNAi, oligonucleotides and delivery technologies
Bioinnovation Group Summit (September 24) — Practical strategies and partnerships to address the barriers limiting innovation adoption
Finance & Accounting for Bioscience (September 24–25) — Financial strategy and capital efficiency for biotech leaders
Industry Leaders and Breakthrough Science
Attendees will gain access to cutting-edge science, practical manufacturing insights, investment opportunities and cross-sector networking that accelerates ideas into partnerships and commercial progress. Highlights include plenary keynotes from industry leaders plus an extensive exhibition showcasing the latest technologies and solutions from more than 250 exhibitors.
"As we celebrate ten years of Biotech Week Boston, we're proud to have created the industry's most comprehensive gathering—where C-suite strategy meets scientific innovation," said Anna Chrisman, President, Pharma and Life Sciences at Informa Connect. "This anniversary edition reflects our industry's evolution. From adding Obesity Science & Innovation to address one of today's most dynamic therapeutic areas, to expanding our manufacturing and investment programming, attendees can move seamlessly from discovery to scale-up, investment and commercialisation—all while connecting with peers shaping the future of medicine."
Media are invited to attend with complimentary press credentials to cover the week's keynotes, panel discussions, exhibition floor and networking events, including the 10th anniversary celebration.
For more information, registration details or media accreditation, please visit: https://informaconnect.com/biotech-week-boston/
About Biotech Week Boston
Biotech Week Boston is an annual series of leading life sciences events taking place across one week in Boston. Now in its 10th year, BWB brings together experts, investors and academics in biologics, bioprocessing, cell and gene therapy, RNA therapeutics, obesity science, AI, data science, and biotechnology—creating a unique opportunity to learn, network, and connect with the wider biotech community.
About Informa Connect Life Sciences
Informa Connect's Life Science Partnering, Investment & Strategy teams' mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference portfolio in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings.
-Ends-
Ryan Hui
Informa Connect
+ +44 20 7551 9521
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.